Exchange: NASDAQ·Updated 07:56 PM EDT
ALGS logo

ALGS Aligos Therapeutics Inc

$6.21
$0.01
(0.16%)
Today
Closed $6.21
$0.03
(0.48%)
After Hours
Reported EarningsAug 6
Mkt Cap$38.78M
Vol20,289.00

About ALGS

Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). The company was founded by Lucinda Quan and Lawrence M. Blatt on February 5, 2018 and is headquartered in South San Francisco, CA.
44

Bearish Sentiment

How do you feel about ALGS?

Advertisement|Remove ads.